Effects of Treatment with Sulfonylureas and β-Blockers in Patients with Type-2 Diabetes

被引：0
|
作者：
Kessing, Richard
机构：
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2023年 / 18卷 / 03期
关键词：
D O I：
10.1055/a-1945-1961
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：174 / 174
页数：1
相关论文
共 50 条
  • [1] SULFONYLUREAS AND OR INSULIN IN TYPE-2 DIABETES
    GROOP, L
    WIDEN, E
    FRANSSILAKALLUNKI, A
    EKSTRAND, A
    DIABETES 1988, 1989, 800 : 357 - 363
  • [2] Treatment for Patients with Type-2 Diabetes
    Landgraf, Ruediger
    Kellerer, Monika
    Aberle, Jens
    Fach, Eva-Maria
    Gallwitz, Baptist
    Hamann, Andreas
    Joost, Hans-Georg
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Schreiber, Stephan
    Siegel, Erhard
    DIABETOLOGE, 2019, 15 (02): : 146 - 167
  • [3] Treatment for Patients with Type-2 Diabetes
    Landgraf, Rueediger
    Aberle, Jens
    Birkenfeld, Andreas L.
    Gallwitz, Baptist
    Kellerer, Monika
    Klein, Harald H.
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Wiesner, Tobias
    Siegel, Erhard
    DIABETOLOGIE UND STOFFWECHSEL, 2021, 16 : S168 - S206
  • [4] TWICE DAILY INSULIN THERAPY IN PATIENTS WITH TYPE-2 DIABETES AND SECONDARY FAILURE TO SULFONYLUREAS
    WOLFFENBUTTEL, BHR
    WEBER, RFA
    WEEKS, L
    VANKOETSVELD, PM
    VERSCHOOR, L
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1990, 13 (02): : 79 - 84
  • [5] The role of sulfonylureas in the treatment of type 2 diabetes
    Tomlinson, Brian
    Patil, Nivritti Gajanan
    Fok, Manson
    Chan, Paul
    Lam, Christopher Wai Kei
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (03) : 387 - 403
  • [6] Treatment of hypertension in patients with type-2 diabetes mellitus
    Kjeldsen, SE
    Os, I
    Farsang, C
    Mallion, JM
    Hansson, L
    Sleight, P
    JOURNAL OF HYPERTENSION, 2000, 18 (09) : 1345 - 1346
  • [7] Treatment of hypertension in patients with type-2 diabetes mellitus
    Kjeldsen, SE
    Os, I
    Farsang, C
    Mallion, JM
    Hansson, L
    Sleight, P
    BLOOD PRESSURE, 2000, 9 (06) : 363 - 364
  • [8] Sulfonylureas as second line treatment for type 2 diabetes
    McGowan, Lucy D'Agostino
    Roumie, Christianne L.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
  • [9] Differential effects of β-blockers on albuminuria in patients with type 2 diabetes
    Bakris, GL
    Fonseca, V
    Katholi, RE
    Mcgill, JB
    Messerli, F
    Phillips, RA
    Raskin, P
    Wright, JT
    Waterhouse, B
    Lukas, MA
    Anderson, KM
    Bell, DSH
    HYPERTENSION, 2005, 46 (06) : 1309 - 1315
  • [10] Effects of troglitazone in patients with type 2 diabetes mellitus not adequately controlled by sulfonylureas
    Bunnag, P
    Puavilai, G
    Chanprasertyotin, S
    Chandraprasert, S
    Suwanwalaikorn, S
    Suthijumroon, A
    Benjasuratwong, Y
    Boonyavarakul, A
    Nitiyanant, W
    Sriussadaporn, S
    Deerochanawong, C
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 51 (02) : 151 - 153
12345